Blood Pressure Monitor and Vascular Screening Devices Market Size, Share Global Analysis Report, 2026-2034

Industry Insights

[243+ Pages Report] According to Facts & Factors, the global Blood Pressure Monitor and Vascular Screening Devices market size was estimated at USD 3.8 billion in 2025 and is expected to reach USD 7.9 billion by the end of 2034. The Blood Pressure Monitor and Vascular Screening Devices industry is anticipated to grow by a CAGR of 8.5% between 2026 and 2034. The Blood Pressure Monitor and Vascular Screening Devices Market is driven by the rising global prevalence of hypertension, cardiovascular diseases, and peripheral artery disease, coupled with increasing adoption of home-based and early screening technologies.

Market Overview

The Blood Pressure Monitor and Vascular Screening Devices market encompasses a range of diagnostic tools used to measure blood pressure and assess vascular health, enabling early detection, monitoring, and management of cardiovascular conditions. Blood pressure monitors include digital, ambulatory, and wrist-based devices that provide accurate readings of systolic and diastolic pressure, while vascular screening devices such as ankle-brachial index (ABI) systems and pulse wave velocity (PWV) analyzers evaluate arterial stiffness, peripheral circulation, and overall vascular function. These devices support clinical decision-making in hypertension management, cardiovascular risk assessment, and peripheral artery disease detection. The market covers both professional-grade equipment for hospitals and clinics and user-friendly home-use models, supported by software for data tracking, telehealth integration, and trend analysis to facilitate proactive chronic disease care.

Key Insights

• As per the analysis shared by our research analyst, the Blood Pressure Monitor and Vascular Screening Devices market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2026-2034).
• In terms of revenue, the Blood Pressure Monitor and Vascular Screening Devices market size was valued at around USD 3.8 billion in 2025 and is projected to reach USD 7.9 billion by 2034.
• The Blood Pressure Monitor and Vascular Screening Devices Market is driven by the rising prevalence of hypertension and cardiovascular diseases.
• Based on the Type, the Blood Pressure Monitors segment dominated the market in 2025 with a share of 68% due to its essential role in routine hypertension screening and widespread home and clinical usage.
• Based on the Product, the Digital Blood Pressure Monitors segment dominated the market in 2025 with a share of 52%, owing to ease of use, accuracy, and affordability for both professional and consumer segments.
• Based on the Application, the Hypertension Management segment dominated the market in 2025 with a share of 65% because of the global burden of high blood pressure requiring continuous monitoring.
• Based on the End-User, the Hospitals & Clinics segment dominated the market in 2025 with a share of 48% due to high patient volume and the need for accurate diagnostic tools.
• North America dominated the global Blood Pressure Monitor and Vascular Screening Devices market in 2025 with a share of 36% attributed to advanced healthcare infrastructure, high awareness of cardiovascular health, and strong adoption of home monitoring devices.

Growth Drivers

• Rising Cardiovascular Disease Burden

The increasing incidence of hypertension, heart disease, and peripheral artery disease, driven by aging populations, sedentary lifestyles, and unhealthy diets, has created substantial demand for reliable blood pressure and vascular screening tools for early detection and ongoing management.

Growing emphasis on preventive healthcare and routine screening programs in both clinical and home settings further accelerates the adoption of these devices.

Restraints

• High Cost of Advanced Devices

Premium vascular screening devices such as ABI and PWV systems remain expensive, limiting their penetration in low- and middle-income countries and smaller clinics despite their clinical value.

Accuracy concerns with some low-cost home blood pressure monitors and the need for periodic calibration reduce user confidence and slow broader consumer adoption.

Opportunities

• Home Healthcare and Telemedicine Integration

The shift toward remote patient monitoring and telehealth creates strong opportunities for connected blood pressure monitors and portable vascular screening devices that enable real-time data sharing with physicians.

Development of affordable, user-friendly multi-parameter devices combining blood pressure with vascular health metrics appeals to aging populations and chronic disease patients seeking convenient home solutions.

Challenges

• Regulatory and Accuracy Requirements

Stringent regulatory approval processes for medical devices and the need for clinical validation of accuracy across diverse patient populations increase development costs and time-to-market for new products.

Lack of standardized protocols for vascular screening in primary care settings hinders consistent utilization and slows market growth in certain regions.

Report Scope

Report Attribute	Details
Market Size 2025	USD 3.8 Billion
Projected Market Size in 2034	USD 7.9 Billion
CAGR Growth Rate	8.5% CAGR
Base Year	2025
Forecast Years	2026-2034
Key Market Players	Omron Healthcare, Philips Healthcare, GE HealthCare, Withings, Welch Allyn, SunTech Medical, Spacelabs Healthcare, A&D Medical, Microlife Corporation, Bosch + Sohn GmbH, and Others.
Key Segment	By Type, By Product, By Application, By End-User, and By Region
Major Regions Covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Purchase Options	Request customized purchase options to meet your research needs. Explore purchase options

Market Segmentation

The Blood Pressure Monitor and Vascular Screening Devices market is segmented by type, product, application, end-user, and region.

Based on Type Segment, the Blood Pressure Monitor and Vascular Screening Devices market is divided into blood pressure monitors and vascular screening devices. The most dominant segment is Blood Pressure Monitors, followed by Vascular Screening Devices. Blood Pressure Monitors dominate due to their universal necessity in hypertension screening and management, high volume of daily usage in both clinical and home environments, and continuous innovation in digital and wearable formats that drive accessibility, affordability, and sustained market growth.

Based on Product Segment, the Blood Pressure Monitor and Vascular Screening Devices market is divided into digital blood pressure monitors, ambulatory blood pressure monitors, wrist blood pressure monitors, ankle-brachial index devices, pulse wave velocity devices, and others. The most dominant segment is Digital Blood Pressure Monitors, followed by Ambulatory Blood Pressure Monitors. Digital Blood Pressure Monitors lead because of their ease of use, affordability, and suitability for both professional and self-monitoring, enabling widespread adoption that supports high sales volumes and encourages technological upgrades across the entire category.

Based on Application Segment, the Blood Pressure Monitor and Vascular Screening Devices market is divided into hypertension management, cardiovascular disease screening, peripheral artery disease detection, and others. The most dominant segment is Hypertension Management, followed by Cardiovascular Disease Screening. Hypertension Management dominates due to the sheer scale of the global hypertensive population requiring regular monitoring, which generates consistent demand for both basic and advanced devices while driving clinical protocols that integrate vascular screening for comprehensive cardiovascular risk assessment.

Based on End-User Segment, the Blood Pressure Monitor and Vascular Screening Devices market is divided into hospitals & clinics, home healthcare, diagnostic centers, ambulatory surgical centers, and others. The most dominant segment is Hospitals & Clinics, followed by Home Healthcare. Hospitals & Clinics dominate as primary diagnostic hubs where accurate professional-grade devices are essential for patient evaluation and treatment planning, creating high-volume institutional demand that supports innovation and paves the way for greater home healthcare adoption.

Recent Developments

• In February 2025, Omron Healthcare launched a new AI-powered upper-arm digital blood pressure monitor with irregular heartbeat detection and vascular health insights.
• In April 2025, Withings introduced a cuffless blood pressure monitor integrated into a smart scale for convenient home vascular screening.
• In November 2024, GE HealthCare expanded its vascular screening portfolio with an advanced ankle-brachial index system for point-of-care use.
• In March 2025, Philips introduced a compact ambulatory blood pressure monitor with improved patient comfort and cloud-based data analytics.
• In June 2025, a leading Japanese manufacturer released a portable pulse wave velocity device targeted at home healthcare and telemonitoring applications.

Regional Analysis

• North America to dominate the global market

North America leads the Blood Pressure Monitor and Vascular Screening Devices market through high cardiovascular disease awareness, advanced healthcare infrastructure, and strong reimbursement support for home monitoring devices. Widespread adoption of preventive screening and telehealth integration further drives demand. The United States dominates within North America due to its large aging population, high prevalence of hypertension, robust distribution networks for consumer devices, and leadership in clinical innovation for vascular health assessment.

Europe holds a significant share in the Blood Pressure Monitor and Vascular Screening Devices market, supported by aging demographics, comprehensive public health systems, and emphasis on early cardiovascular risk detection. Standardized clinical guidelines promote the routine use of ambulatory and vascular screening tools. Germany stands out through its advanced medical technology sector, strong focus on preventive care, and high adoption rates in both hospital and home settings.

Asia Pacific is experiencing rapid growth in the Blood Pressure Monitor and Vascular Screening Devices market, driven by rising hypertension rates linked to lifestyle changes, improving healthcare access, and government initiatives for non-communicable disease management. Expanding middle-class populations increase demand for home monitoring solutions. China dominates the region with its massive population, growing chronic disease burden, and rapid expansion of digital health and home healthcare markets.

Latin America shows steady progress in the Blood Pressure Monitor and Vascular Screening Devices market as awareness of cardiovascular health improves and healthcare infrastructure modernizes. Urbanization and rising disposable incomes support greater adoption of monitoring devices. Brazil leads through its large healthcare market and increasing focus on chronic disease screening programs.

The Middle East & Africa region demonstrates emerging potential in the Blood Pressure Monitor and Vascular Screening Devices market, supported by investments in modern hospitals and a growing focus on lifestyle-related diseases in urban areas. Improving primary care access aids gradual uptake. The United Arab Emirates dominates with its advanced healthcare facilities, high expatriate population, and commitment to preventive health technologies.

Competitive Analysis

The global Blood Pressure Monitor and Vascular Screening Devices market is dominated by players:

• Omron Healthcare
• Philips Healthcare
• GE HealthCare
• Withings
• Welch Allyn
• SunTech Medical
• Spacelabs Healthcare
• A&D Medical
• Microlife Corporation
• Bosch + Sohn GmbH

The global Blood Pressure Monitor and Vascular Screening Devices market is segmented as follows:

By Type

• Blood Pressure Monitors
• Vascular Screening Devices

By Product

• Digital Blood Pressure Monitors
• Ambulatory Blood Pressure Monitors
• Wrist Blood Pressure Monitors
• Ankle-Brachial Index Devices
• Pulse Wave Velocity Devices
• Others

By Application

• Hypertension Management
• Cardiovascular Disease Screening
• Peripheral Artery Disease Detection
• Others

By End-User

• Hospitals & Clinics
• Home Healthcare
• Diagnostic Centers
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America